FDA Review Adds To Hospira's Regulatory Woes
Hospira Inc. disclosed Wednesday that the U.S. Food and Drug Administration had uncovered a number of potential quality-control violations at one of company's sites, adding to the device maker's recent regulatory...To view the full article, register now.
Already a subscriber? Click here to view full article